Across TCGA pan-cancer cohorts, IGLL3P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated IGLL3P data layer compared with 18 for mass-spec protein.

The strongest signal is observed in mesothelioma (MESO), where higher IGLL3P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IGLL3P expression acts as an unfavorable survival marker.

MESO are the cancer types where IGLL3P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.169	0.556	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: IGLL3P tumor-vs-normal RNA expression · all IGLL3P data types